Altamira Therapeutics (CYTOF) Q2 2025 Earnings

30AprConfirmed
Q1 1
Q3 2024
Q2 2025
-2.38
-1.77
-1.15
-0.54

Details

Expected EPS
-0.53563027572
Actual EPS
N/A
Surprise EPS
0.54
Surprise Percent
+100%

Description

Altamira Therapeutics (CYTOF) will report earnings of for Q2 2025 on April 30, 2025.

0 Comments

Share your thoughts